Therefore, it is reasonable to assume that the presence of gene variants encoding for regulatory and catalytic antioxidant proteins, such as NRF2, GTSM3, SOD2 and GPX3 polymorphisms, functionally resulting in altered levels of antioxidant defense, may affect the risk of tumor development, including testicular tumors. This evidence concerns the gene NFE2L2 and neoplasm.